Author

M. I. Barria

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Approach:statistical model· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:host-pathogen & immune response· 1 Assay:proteomics· 1

Frequent Co-Authors

M. Calvo· 2 shared R. A. Alvarez· 2 shared C. D. Bahl· 1 shared C. Kossack· 1 shared C. Quevedo· 1 shared F. Aguilera· 1 shared F. Bravo· 1 shared F. Fuentes· 1 shared

Activity by Year

2021-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 30 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

M. Calvo

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Longitudinal transcriptional changes reveal genes from the natural killer cell-mediated cytotoxicity pathway as critical players underlying COVID-19 progression

M. A. Medina, F. Fuentes-Villalobos, C. Quevedo, F. Aguilera, R. Riquelme, M. L. Rioseco, S. Barria, Y. Pinos, M. Calvo, I. Burbulis, C. Kossack, R. A. Alvarez, J. L. Garrido, M. I. Barria

The paper identifies genes from the natural killer cell-mediated cytotoxicity pathway as critical in determining clinical outcomes of COVID-19 by analyzing longitudinal transcriptional changes in immune cells.

bioRxiv · Jan 2, 2024Immunology

Humoral immune responses against seasonal coronaviruses predict efficiency of SARS-CoV-2 spike targeting, FcγR activation, and corresponding COVID-19 disease severity

J. J. Garrido, M. Medina, F. Bravo, S. McGee, F. Fuentes, M. Calvo, J. W. Bowman, C. D. Bahl, M. I. Barria, R. A. Brachman, R. A. Alvarez

The paper shows that humoral immune responses against seasonal coronaviruses correlate with SARS-CoV-2 disease severity and antibody targeting of specific epitopes.

bioRxiv · Sep 14, 2021 · PreprintMicrobiology